Menu

Blog

Archive for the ‘biotech/medical’ category: Page 35

Dec 4, 2024

AI Just Beat Doctors at Diagnosing Illness (Here’s Why That’s Actually GREAT News)

Posted by in categories: biotech/medical, health, robotics/AI

A groundbreaking study just revealed AI outperforming human doctors at medical diagnosis — but before you panic, this could be the best news yet for healthcare.

This hits personally for me. From my kiddo’s misdiagnosed case of hives to my own health struggles with multiple doctors, I’ve seen firsthand why we need AI to empower (not replace) medical professionals. I’m sure I’m not the only one.

Continue reading “AI Just Beat Doctors at Diagnosing Illness (Here’s Why That’s Actually GREAT News)” »

Dec 4, 2024

Engineers Create a Lollipop That Brings Taste to Virtual Reality

Posted by in categories: biotech/medical, virtual reality

The dream of many – to try the taste through a monitor – is getting closer.

Remove ads and unlock PREMIUM content

A team of biomedical engineers and virtual reality experts has developed a groundbreaking lollipop-shaped interface that simulates taste in virtual reality.

Dec 4, 2024

New synthetic receptor expands cellular control options, including immune response and neurological signaling

Posted by in category: biotech/medical

A basic function of cells is that they act in response to their environments. It makes sense, then, that a goal of scientists is to control that process, making cells respond how they want to what they want.

One avenue for this ambition is , which function like ignition slots on a cell, requiring keys—such as specific hormones, drugs, or antigens—to start up specific cellular activities. There are already synthetic receptors that give us some control over this sequence of events, most famously the chimeric antigen receptors used in CAR-T cell cancer therapy. But existing synthetic receptors are limited in the variety of keys they can accept and the activities they can trigger.

Now, detailed in a paper published in Nature, Stanford researchers have developed a new synthetic receptor that accommodates a broader range of inputs and produces a more diverse set of outputs.

Dec 4, 2024

Dr. Amal Al-Maani, MD — Director General, Diseases Surveillance & Control, Ministry of Health, Oman

Posted by in categories: biotech/medical, health

Multisectoral approaches for combating antimicrobial resistance — dr. amal al-maani — director general, diseases surveillance & control, ministry of health oman.


Dr. Amal Al-Maani, MD is Director General for Diseases Surveillance and Control at the Ministry of Health of Oman (https://moh.gov.om/en/hospitals-direc…), senior consultant in pediatric infectious diseases in the Sultanate, and is the focal point for the Global Antimicrobial Resistance (AMR) Surveillance System (GLASS) and is responsible for Oman national surveillance system for AMR (OMASS) and the national Infection Prevention and Control (IPC) program.

Continue reading “Dr. Amal Al-Maani, MD — Director General, Diseases Surveillance & Control, Ministry of Health, Oman” »

Dec 4, 2024

Autism study reveals pivotal role of neuronal protein CPEB4 condensates

Posted by in categories: biotech/medical, genetics, neuroscience

Autism is a neurodevelopmental disorder characterized by difficulties in communication and social behavior. Approximately 20% of cases are linked to a specific genetic mutation, but the origin of the remaining 80%, known as idiopathic autism, remains a mystery.

A team of scientists led by Drs. Raúl Méndez and Xavier Salvatella at the Institute for Research in Biomedicine (IRB Barcelona) has identified a that explains why certain alternations of the neuronal protein CPEB4 are associated with idiopathic autism.

The study is based on previous work published in 2018 that identified CPEB4 as a key protein in the regulation of neuronal proteins related to autism.

Dec 4, 2024

Scientists discover Novel Metabolic Compound that can Regulate Body Weight

Posted by in categories: biotech/medical, health, neuroscience

Researchers at Baylor College of Medicine, Stanford University School of Medicine and collaborating institutions report in the journal Cell the discovery of BHB-Phe, a novel compound produced by the body that regulates appetite and body weight through interactions with neurons in the brain.

Until now, BHB has been known as a compound produced by the liver to be used as fuel. However, in recent years, scientists have found that BHB increases in the body after fasting or exercise, prompting interest in investigating potential beneficial applications in obesity and diabetes.

In the current study, the team at Stanford University led by co-corresponding author Dr. Jonathan Z. Long, associate professor of pathology, discovered that BHB also participates in another metabolic pathway. In this case, an enzyme called CNDP2 joins BHB to amino acids. Furthermore, the most abundant BHB-amino acid, BHB-Phe, can influence body weight and metabolism in animal models.

Dec 4, 2024

MRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine

Posted by in categories: biotech/medical, nanotechnology

A new Science Advances study demonstrates a vaccine for cancer immunotherapy that would speed up the efficiency of messenger RNA translation in cytoplasm—and effectively inhibited tumor growth.

Dec 4, 2024

A New Method to Map the Brain: Infect It With a Virus

Posted by in categories: biotech/medical, neuroscience

A lab named E11 is working on a novel technique to produce a detailed map of a mouse brain.

Dec 4, 2024

DeepMind’s AlphaProteo: The Future of Biotech is Here

Posted by in categories: biotech/medical, robotics/AI

Learn how AlphaProteo is transforming healthcare, drug development, and environmental sustainability with AI-designed custom proteins.

Dec 4, 2024

ATP dynamics of specialized cells yield new insights into acute kidney injury

Posted by in category: biotech/medical

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body is restricted, depriving tissues of oxygen and nutrients. This damage is commonly followed by reperfusion (that is, the restoration of blood flow), but this process can sometimes exacerbate injury through oxidative stress and inflammation. This is called ischemia-reperfusion injury.

AKI remains a significant clinical challenge with limited treatment options and poor outcomes. Recent studies suggest that proteinuria, where protein leaks into the urine, is a common feature and associated with poor long-term renal prognosis after AKI. However, the mechanisms underlying proteinuria and its links to kidney cell damage are still unclear.

In a new study published in Nature Communications, researchers in Japan led by Dr. Motoko Yanagita focused on the role of podocytes, which are specialized kidney cells crucial to filtering blood. In particular, they looked at the energy requirements of these cells during .

Page 35 of 2,801First3233343536373839Last